|
[1] Chalasani
NP, Maddur H, Russo MW, et al. ACG clinical guideline: diagnosis and management
of idiosyncratic drug-induced liver injury [J]. Am J Gastroenterol, 2021,
116(5): 878-898. DOI: 10.14309/ajg.0000000000001259.
[2] Yang MM, Fan P, Gao YY, et al. Liver
injury induced by piperacillin sodium and tazobactam sodium [J].ADRJ, 2016,
18(6): 466-467.
[3] 柳丽丽,冯毅,刘文生,等. 1例坎地沙坦致不良反应慢病患者实施药物治疗管理的实践[J]. 中国药房,2019,30(11):1559-1564.
DOI:10.6039/j.issn.1001-0408.2019.11.24.
[4] 钱佩佩,卢鸽,潘威霖,等. 我国药品不良反应关联性评价方法与诺氏评估量表法的对比与分析[C]. //中华医学会临床药学分会2019年全国学术会议论文集. 2019: 99-100.
[5] Cabañas R, Calderon O, Ramirez E, et al.
Piperacillin-induced DRESS: distinguishing features observed in a clinical and
allergy study of 8 patients [J]. J Investig Allergol Clin Immunol, 2014, 24(6):
425-430.
[6] 谭孝琼,杨光谦,张林,等. 细胞色素P4502 E1介导外源性化合物毒性损伤研究进展[J]. 中国职业医学,2016,43(2):234-236. DOI:10.11763/j.issn.2095-2619.2016.02.026.
[7] 寻玉君,单鹏. 他汀类药物的不良反应评价[J]. 国际医药卫生导报,2019,25(16):2764-2766.
DOI:10.3760/cma.j.issn.1007-1245.2019.16.048.
[8] Aghdassi AA, Kraft M, Domschke W, et al.
Genetic polymorphisms in the UDP-glucuronosyltransferase UGT1A7 gene in
patients with acute liver failure after kava-kava consumption [J]. Arch
Toxicol, 2015,89(11):2173-2174. DOI:10.1007/s00204-015-1578-6.
[9] Zhang ST, Wan GJ, LI L. Research
advances in the mechanism of drug-induced liver injury[J].Pharm Care Res, 2017,
17(1): 39-42.
[10] Dietze MA, Martin P, Schaaf-Lafontaine
N. Le cas clinique du mois. Hépatite cholestatique après administration de
pipéracilline [Clinical case of the month. Cholestatic hepatitis after
administration of piperacillin]. Rev Med Liege, 2002, 57(9): 571-574.
[11] He ZF, Wu XA, Wang YP. Severe bone
marrow suppression and hepatic dysfunction caused by piperacillin/tazobactam
[J]. Scand J Infect Dis, 2013, 45(11):885-887. DOI:
10.3109/00365548.2013.805426.
[12] Kraleti S, Khatri N, Jarrett D.
Piperacillin-tazobactam induced interstitial nephritis, hepatitis and serum
Sckness-like illness [J]. J Ark Med Soc, 2016, 112(14):278-280.
[13] Benesic A, Rotter I, Dragoi D, et al.
Development and validation of a test to identify drugs that cause idiosyncratic
drug-induced liver injury [J]. Clin Gastroenterol Hepatol, 2018, 16(9):
1488-1494.e5. DOI: 10.1016/j.cgh.2018.04.049. |
